Literature DB >> 1801553

The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease.

D Y Leung1.   

Abstract

Kawasaki disease (KD) is an acute febrile illness of infancy and early childhood characterized by diffuse vasculitis. Although the disease is generally self-limited, up to 30% of untreated patients with KD may develop coronary artery (CA) abnormalities. The acute phase of KD is characterized by marked activation of the immune system leading to increased cytokine production by immune effector cells, the induction of activation antigens on their vascular endothelium and the generation of lytic antibodies directed against vascular endothelial cells (EC) stimulated with cytokines. Treatment with intravenous gammaglobulin (IVGG) usually rapidly reduces acute clinical symptoms and prevents CA abnormalities. Immunologically, successful IVGG treatment is associated with decreased lymphocyte activation, reduced cytokine secretion and the loss of cytokine induced expression of leukocyte adhesion molecules on vascular endothelium. The association between improvement of clinical symptoms with the reduction of cytokine secretion, and reversal of EC activation supports a role for immune mediated injury to cytokine induced EC antigens in the pathogenesis of this disorder.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1801553     DOI: 10.1111/j.1442-200x.1991.tb02602.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  8 in total

1.  Dilation of the aortic root in children infected with human immunodeficiency virus type 1: The Prospective P2C2 HIV Multicenter Study.

Authors:  W W Lai; S D Colan; K A Easley; S E Lipshultz; T J Starc; J T Bricker; S Kaplan
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

2.  The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin.

Authors:  T Hohlfeld; P Klemm; C Thiemermann; T D Warner; K Schrör; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease.

Authors:  Marianna Fabi; Emanuele Filice; Laura Andreozzi; Bianca Elisa Mattesini; Alessia Rizzello; Daniela Palleri; Elton Dajti; Rocco Maurizio Zagari; Marcello Lanari
Journal:  Sci Rep       Date:  2022-05-23       Impact factor: 4.996

4.  Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease.

Authors:  M C Nash; V Shah; M J Dillon
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

Review 5.  Pediatric vasculitis.

Authors:  Pamela F Weiss
Journal:  Pediatr Clin North Am       Date:  2012-04-06       Impact factor: 3.278

6.  Perioperative considerations of kawasaki disease.

Authors:  Lisa To; Stephen T Krazit; Alan D Kaye
Journal:  Ochsner J       Date:  2013

7.  IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway.

Authors:  Chang Jia; Yingzhi Zhuge; Shuchi Zhang; Chao Ni; Linlin Wang; Rongzhou Wu; Chao Niu; Zhengwang Wen; Xing Rong; Huixian Qiu; Maoping Chu
Journal:  Cell Death Dis       Date:  2021-06-03       Impact factor: 8.469

8.  Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease.

Authors:  Hyun Hee Lee; In Ho Park; Jeon-Soo Shin; Jun Soo Shin; Dong Soo Kim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.